会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Sustained release pharmaceutical compositions
    • 持续释放药物组合物
    • US4539199A
    • 1985-09-03
    • US384084
    • 1982-06-01
    • Erno OrbanJanos BorvendegLaszlo NagyMarta Sotinee TolvayErzsebet Bander
    • Erno OrbanJanos BorvendegLaszlo NagyMarta Sotinee TolvayErzsebet Bander
    • A61K47/48A01N25/12A61K31/78
    • A61K47/48176
    • Pharmaceutical compositions for sustained release of pharmaceutical compounds comprising a reaction product of a water soluble salt of a pharmaceutically active compound containing a primary, secondary or tertiary amino group, and an alkali or ammonium salt of a synthetic copolymer containing an acid group, and selected from the group consisting of methacrylic acid/methacrylic acid methyl ester, methacrylic acid/acrylic acid methyl ester and methacrylic acid/acrylic acid methyl ester/methacrylic acid methyl ester copolymers and a pharmaceutically acceptable excipient. The water soluble salt of a pharmaceutically active compound containing a primary, secondary or tertiary amino group is reacted in aqueous medium with an alkali or ammonium salt of a copolymer selected from the group consisting of the above mentioned copolymers, and the resulting product is converted into a pharmaceutical composition.
    • 用于持续释放药物组合物的药物组合物,其包含含有伯,仲或叔氨基的药物活性化合物的水溶性盐与含有酸基的合成共聚物的碱金属盐或铵盐的反应产物,并且选自 由甲基丙烯酸/甲基丙烯酸甲酯,甲基丙烯酸/丙烯酸甲酯和甲基丙烯酸/丙烯酸甲酯/甲基丙烯酸甲酯共​​聚物和药学上可接受的赋形剂组成的组。 含有伯,仲或叔氨基的药物活性化合物的水溶性盐在水性介质中与选自上述共聚物的共聚物的碱金属盐或铵盐反应,将所得产物转化为 药物组合物。